ANNLISE CALYPSO: Open Payments
NPI 1114449493 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,050 in 9 payments from 2 companies in 2025. Trend: 2023 $119 · 2024 $411 · 2025 $3,050
Consulting: $2,475Food & beverage: $435Travel & lodging: $140
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $2,952 |
| United Therapeutics Corporation | 2 | $98 |
Products named: JASCAYD.
Industry payments across MD — which companies pay providers there.
